U.S. FDA Clears EkoSonic® Endovascular System for Treatment of Pulmonary Embolism

EKOS Corporation has gained U.S. FDA clearance to market its EkoSonic® Endovascular System for the ultrasound-facilitated, controlled and selective infusion of physician-specified fluids, including thrombolytics, into the vasculature for the treatment of pulmonary embolism (PE).

Most read

Latest

^